Poly Medicure Peer Comparison

NSE: POLYMED | BSE: 531768

₹1,586.80

₹90.60 (6.06%)

As on 04-Nov-2026IST

Market cap

₹16,093 Cr

Revenue (TTM)

₹1,997 Cr

P/E Ratio

51.1

P/B Ratio

5.1

Div. Yield

0.2 %

Edit

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Market cap (₹ Cr)	16,093	334	288	194	169
Revenue (₹ Cr)	1,997	183	174	34	94
Net Profit (₹ Cr)	307.01	12.72	4.76	-4.78	2.37
Net Margin (%)	14.56	6.90	2.64	-13.48	2.51
RoE (%)	10.63	10.39	2.58	-30.48	6.25
Price to Earnings	51.07	30.66	60.47	--	71.24
Price-To-Book	5.06	--	1.53	11.06	3.46

Income Statement (₹ Cr)

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Operating Revenue	1,875.26	--	146.96	34.50	80.01
Total Income	2,002.19	--	155.06	35.66	80.58
Total Expenditure	1,436.66	--	146.78	33.78	68.25
EBITDA	438.59	--	0.18	0.72	11.76
Depreciation	115.52	--	2.02	4.06	2.04
EBIT	323.08	--	-1.84	-3.34	9.72
Interest	21.42	--	1.28	2.29	3.96
Other Income	126.93	--	8.10	1.16	0.56
Exceptional Items	-6.80	--	--	--	--
Profit before Tax	427.47	--	4.98	-4.47	6.32
Provision for Tax	106.74	--	2.90	-0.12	4.51
Profit after Tax	320.73	--	2.08	-4.35	1.81

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Shareholder's Funds	3,106.17	--	180.76	11.25	46.74
Minority Interest	43.07	--	--	1.36	--
Non-Current Liabilities	120.16	--	-0.92	15.91	39.30
Current Liabilities	666.53	--	13.78	7.35	35.31
Total Liabilities	3,951.60	--	196.16	36.00	121.35

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Non-Current Assets	1,903.19	--	78.94	21.90	70.90
Current Assets	2,032.74	--	114.68	13.96	50.45
Total Assets	3,951.60	--	196.16	36.00	121.35
Total Debt*	341.62	--	0.72	9.65	64.13
Net Current Assets	1,366.21	--	100.90	6.61	15.14
Contingent Liabilities	50.21	--	4.73	--	--

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Cash From Operating Activities	246.37	--	3.30	-6.16	3.67
Cash Flow from Investing Activities	-225.38	--	14.49	-4.88	-34.95
Cash from Financing Activities	20.15	--	-19.56	11.87	44.23
Net Cash Inflow / Outflow	41.14	--	-1.77	0.84	12.95

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
ROCE (%)	14.05	--	3.31	3.64	11.94
ROE (%)	10.94	--	1.11	-71.25	4.91
ROA (%)	8.89	--	1.04	-6.59	1.91
EBIT Margin (%)	30.16	--	5.63	5.44	15.41
Net Margin (%)	16.02	--	1.34	-12.20	2.25
Cash Profit Margin (%)	23.12	--	2.57	6.93	4.81

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Revenue Growth (%)	12.30	--	34.02	149.39	28.19
EBIT Growth (%)	3.80	--	69.11	-55.15	39.58
Net Profit Growth (%)	-5.27	--	145.86	48.05	-70.48
EPS Growth (%)	-4.88	--	157.91	48.32	-76.32
Book Value Growth (%)	12.14	--	-6.96	-46.81	73.66

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Price / Earnings	37.47	--	94.46	0.00	64.26
Price / Book Value	3.90	--	1.09	36.61	2.49
Dividend Yield (%)	0.29	--	0.00	0.00	0.00
EV/EBITDA	21.79	--	18.84	17.05	13.58
Market Cap (₹ Cr)	12,069.92	--	196.67	64.81	116.30

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Debt to Equity	0.11	--	0.00	4.17	1.37
Short term debt to equity ratio	0.08	--	0.00	0.35	0.44
Current Ratio	3.05	--	8.32	1.45	1.43
Quick Ratio	2.40	--	4.88	0.79	1.01
Interest Coverage	20.96	--	4.88	0.17	2.60

	Poly Medicure	QMS Medical	Nureca	Alan Scott	Raaj Medisafe
Debtors to sales (%)	28.33	--	5.27	1.77	14.69
Asset Turnover	0.52	--	0.80	1.04	0.85
Receivable days	85.20	--	12.70	6.55	64.89
Inventory Days	69.58	--	100.27	52.69	52.52
Payable days	77.97	--	22.92	33.92	33.26
Cash Conversion Cycle	76.82	--	90.04	25.31	84.16

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.